SEC 13F Intelligence

Managers / Q1 2026

PERKINS CAPITAL MANAGEMENT INC

CIK 0000884300 · 730 EAST LAKE STREET, WAYZATA, MN, 55391-1769 · 9524738367

Reported Value
$107M
Q1 2026
Positions
86
Filings on Record
29
2019–present window
Filed
Apr 23, 2026
original filing

Summary

Perkins Capital Management Inc reported $107M in U.S.-listed holdings across 86 positions for Q1 2026.

Its largest position, NTRA, represents 8.3% of the portfolio.

Compared with Q4 2025, the fund opened 4 new positions and exited 9.

Portfolio Metrics

Turnover
+7.9%
vs prior filed quarter
Top-10 Concentration
+45.8%
share of reported value
Largest Position
+8.3%
Natera
New / Exited
4 / 9
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $129MQ4 ’18Q1 ’19: $152MQ2 ’19: $143MQ3 ’19: $116MQ4 ’19: $112MQ4 ’19Q1 ’20: $83MQ3 ’20: $109MQ4 ’20: $153MQ1 ’21: $173MQ1 ’21Q2 ’21: $176MQ3 ’21: $162MQ4 ’21: $148MQ1 ’22: $122MQ1 ’22Q2 ’22: $97MQ3 ’22: $89MQ1 ’23: $106,059Q2 ’23: $114,754Q2 ’23Q3 ’23: $100,871Q4 ’23: $117,077Q1 ’24: $119,922Q2 ’24: $106,132Q2 ’24Q4 ’24: $113MQ1 ’25: $95MQ2 ’25: $99MQ3 ’25: $113MQ3 ’25Q4 ’25: $126MQ1 ’26: $107Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 93.0%Other: 6.6%ADR: 0.4%
  • Common Stock · 93.0% · $99M
  • Other · 6.6% · $7M
  • ADR · 0.4% · $432,400

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TLSITRISALUS LIFE SCIENCES INCNEW+230.1K230.1K+$920,404$920,404
SPAISAFE PRO GROUP INCNEW+231.3K231.3K+$881,062$881,062
SEAGATE TECHNOLOGY HLDNGS PLNEW+550550+$215,468$215,468
MRNAMODERNA INCNEW+4.0K4.0K+$203,200$203,200
XGNEXAGEN INCADDED+53.2K71.8K+$102,452$215,388
APPSDIGITAL TURBINE INCSOLD OUT−366.1K0−$2M$0
VELOVELO3D INCSOLD OUT−87.0K0−$1M$0
DAWNGBXDAY ONE BIOPHARMACEUTICALSSOLD OUT−84.0K0−$782,880$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NTRANATERA INChistory →COM8.30%$9M44.3K
2LLYELI LILLY & COhistory →COM7.61%$8M8.8K
3AXGNAXOGEN INChistory →COM5.24%$6M168.8K
4IDXXIDEXX LABS INChistory →COM5.11%$5M9.7K
5MSFTMICROSOFT CORPhistory →COM3.96%$4M11.4K
6BFLYBUTTERFLY NETWORK INChistory →COM CL A3.52%$4M930.9K
7CIENCIENA CORPhistory →COM NEW3.23%$3M6.3K
8MDXHEALTH SASHS NEW3.18%$3M1.48M
9AMDADVANCED MICRO DEVICES INChistory →COM2.96%$3M15.5K
10QUIKQUICKLOGIC CORPhistory →COM NEW2.70%$3M306.7K
11LMATLEMAITRE VASCULAR INChistory →COM2.64%$3M25.8K
12OOMAOOMA INChistory →COM2.47%$3M181.3K
13VCYTVERACYTE INChistory →COM2.27%$2M75.3K
14ABTABBOTT LABORATORIEShistory →COM1.99%$2M20.7K
15ATECALPHATEC HLDGS INChistory →COM NEW1.75%$2M171.8K
16ONDSONDAS HOLDINGShistory →COM NEW1.71%$2M202.0K
17CYRXCRYOPORT INChistory →COM PAR $0.0011.58%$2M203.2K
18NEOGNEOGEN CORPhistory →COM1.55%$2M178.0K
19PERION NETWORK LTDSHS NEW1.47%$2M156.9K
20PSNLPERSONALIS INChistory →COM1.43%$2M239.0K
21MGNIMAGNITE INChistory →COM1.33%$1M119.3K
22LUCDLUCID DIAGNOSTICS INChistory →COM1.21%$1M1.13M
23INGNINOGEN INChistory →COM1.16%$1M199.6K
24INUVINUVO INChistory →COM1.13%$1M582.3K
25CXDOCREXENDO INChistory →COM1.13%$1M194.8K
26BLZEBACKBLAZE INChistory →COM CL A1.10%$1M339.0K
27ABBVABBVIE INChistory →COM1.09%$1M5.3K
28NEUROONE MEDICAL TECHNOLOGIESCOM NEW1.07%$1M1.47M
29PFEPFIZER INCCOM0.95%$1M35.9K
30GILDGILEAD SCIENCES INCCOM0.94%$1M7.2K
31NEONEOGENOMICS INCCOM NEW0.92%$982,037132.3K
32MRKMERCK & CO INCCOM0.87%$932,2477.8K
33TLSITRISALUS LIFE SCIENCES INCCOM0.86%$920,404230.1K
34ZETAZETA GLOBAL HOLDINGS CORPCL A0.83%$889,92855.9K
35SPAISAFE PRO GROUP INCCOM0.83%$881,062231.3K
36TELATELA BIO INCCOM0.82%$879,3631.42M
37CDXSCODEXIS INCCOM0.81%$859,825527.5K
38USIOUSIO INCCOM0.75%$800,202701.9K
39ELUTELUTIA INCCL A COM0.74%$794,738756.9K
40CPSHCPS TECHNOLOGIES CORPCOM0.70%$750,187200.6K
41ATRCATRICURE INCCOM0.70%$744,63326.1K
42VTRSVIATRIS INCCOM0.70%$741,63154.9K
43PRNPROFOUND MED CORPCOM NEW0.69%$740,534114.3K
44SKYTSKYWATER TECHNOLOGY INCCOM0.68%$723,62426.4K
45BKSYBLACKSKY TECHNOLOGY INCCL A NEW0.68%$723,35028.8K
46AAPLAPPLE INCCOM0.63%$672,5432.6K
47USBUS BANCORPCOM NEW0.61%$652,72512.6K
48BDSXBIODESIX INCCOM0.61%$649,35344.8K
49COPCONOCOPHILLIPSCOM0.60%$640,2004.8K
50CELCCELCUITY INCCOM0.58%$616,3565.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$107M86Apr 23, 202613F-HRchanges · EDGAR ↗
Q4 2025$126M91Feb 4, 202613F-HRchanges · EDGAR ↗
Q3 2025$113M83Oct 31, 202513F-HRchanges · EDGAR ↗
Q2 2025$99M83Aug 7, 202513F-HRchanges · EDGAR ↗
Q1 2025$95M82May 7, 202513F-HRchanges · EDGAR ↗
Q4 2024$113M81Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024Under review84Oct 31, 202413F-HRchanges · EDGAR ↗
Q2 2024$106,13288Aug 9, 202413F-HRchanges · EDGAR ↗
Q1 2024$119,92290May 9, 202413F-HRchanges · EDGAR ↗
Q4 2023$117,07792Jan 22, 202413F-HRchanges · EDGAR ↗
Q3 2023$100,87198Nov 2, 202313F-HRchanges · EDGAR ↗
Q2 2023$114,75497Jul 21, 202313F-HRchanges · EDGAR ↗
Q1 2023$106,05997May 9, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review100Jan 26, 202313F-HRchanges · EDGAR ↗
Q3 2022$89M104Oct 24, 202213F-HRchanges · EDGAR ↗
Q2 2022$97M105Jul 29, 202213F-HRchanges · EDGAR ↗
Q1 2022$122M110Apr 20, 202213F-HRchanges · EDGAR ↗
Q4 2021$148M109Feb 10, 202213F-HRchanges · EDGAR ↗
Q3 2021$162M106Oct 25, 202113F-HRchanges · EDGAR ↗
Q2 2021$176M106Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$173M105Apr 28, 202113F-HRchanges · EDGAR ↗
Q4 2020$153M100Feb 9, 202113F-HRchanges · EDGAR ↗
Q3 2020$109M93Oct 28, 202013F-HRchanges · EDGAR ↗
Q1 2020$83M107Apr 29, 202013F-HRchanges · EDGAR ↗
Q4 2019$112M112Feb 3, 202013F-HRchanges · EDGAR ↗
Q3 2019$116M112Oct 23, 201913F-HRchanges · EDGAR ↗
Q2 2019$143M110Aug 9, 201913F-HRchanges · EDGAR ↗
Q1 2019$152M124Apr 22, 201913F-HRchanges · EDGAR ↗
Q4 2018$129M126Feb 11, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.